KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for BeOne Medicines (ONC) over the last 11 years, with Q3 2025 value amounting to $1.1 billion.

  • BeOne Medicines' Total Non-Current Liabilities rose 20716.46% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 20716.46%. This contributed to the annual value of $373.8 million for FY2024, which is 1835.73% down from last year.
  • Per BeOne Medicines' latest filing, its Total Non-Current Liabilities stood at $1.1 billion for Q3 2025, which was up 20716.46% from $318.1 million recorded in Q2 2025.
  • In the past 5 years, BeOne Medicines' Total Non-Current Liabilities registered a high of $1.1 billion during Q3 2025, and its lowest value of $318.1 million during Q2 2025.
  • Over the past 5 years, BeOne Medicines' median Total Non-Current Liabilities value was $527.4 million (recorded in 2022), while the average stood at $569.8 million.
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first plummeted by 3435.37% in 2022, then skyrocketed by 20716.46% in 2025.
  • Over the past 5 years, BeOne Medicines' Total Non-Current Liabilities (Quarter) stood at $803.4 million in 2021, then crashed by 34.35% to $527.4 million in 2022, then decreased by 13.19% to $457.8 million in 2023, then fell by 18.36% to $373.8 million in 2024, then soared by 203.6% to $1.1 billion in 2025.
  • Its last three reported values are $1.1 billion in Q3 2025, $318.1 million for Q2 2025, and $358.3 million during Q1 2025.